GAMCO Investors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.49M | Sell |
89,200
-4,000
| -4% | -$67K | 0.01% | 593 |
|
2025
Q1 | $1.43M | Sell |
93,200
-12,400
| -12% | -$191K | 0.02% | 530 |
|
2024
Q4 | $2.33M | Sell |
105,600
-24,100
| -19% | -$531K | 0.02% | 479 |
|
2024
Q3 | $2.34M | Sell |
129,700
-4,550
| -3% | -$82K | 0.02% | 483 |
|
2024
Q2 | $2.18M | Sell |
134,250
-10,800
| -7% | -$176K | 0.02% | 482 |
|
2024
Q1 | $2.05M | Sell |
145,050
-2,750
| -2% | -$38.8K | 0.02% | 492 |
|
2023
Q4 | $1.54M | Hold |
147,800
| – | – | 0.02% | 527 |
|
2023
Q3 | $1.51M | Sell |
147,800
-600
| -0.4% | -$6.12K | 0.02% | 524 |
|
2023
Q2 | $1.12M | Sell |
148,400
-4,000
| -3% | -$30.1K | 0.01% | 562 |
|
2023
Q1 | $1.35M | Sell |
152,400
-4,400
| -3% | -$38.9K | 0.01% | 541 |
|
2022
Q4 | $1.43M | Sell |
156,800
-1,600
| -1% | -$14.6K | 0.02% | 530 |
|
2022
Q3 | $1.28M | Sell |
158,400
-17,500
| -10% | -$141K | 0.02% | 533 |
|
2022
Q2 | $1.32M | Sell |
175,900
-12,200
| -6% | -$91.8K | 0.01% | 535 |
|
2022
Q1 | $1.77M | Buy |
188,100
+500
| +0.3% | +$4.69K | 0.02% | 526 |
|
2021
Q4 | $1.5M | Sell |
187,600
-10,000
| -5% | -$80.1K | 0.01% | 553 |
|
2021
Q3 | $1.93M | Hold |
197,600
| – | – | 0.02% | 515 |
|
2021
Q2 | $1.96M | Buy |
197,600
+29,200
| +17% | +$289K | 0.02% | 528 |
|
2021
Q1 | $1.94M | Buy |
+168,400
| New | +$1.94M | 0.02% | 515 |
|